WhiteOak Capital Pharma and Healthcare Fund Regular Growth
- Sector - Healthcare
- Equity
- Very High Risk
Explore On
Rating:
Key Metrics
Aum
₹556.42 Cr
Expense Ratio
2.35%
Exit Load
0.00%
Min. Investment
₹500.00
Min. SIP
₹100.00
Launch Date
6 Feb 2024
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +11.28% | -- |
| 3 Months | +11.76% | -- |
| 6 Months | +4.99% | -- |
| 1 Year | +15.8% | +15.8% |
| 2 Years | -- | +21.66% |
| 3 Years | -- | 0% |
| 5 Years | -- | 0% |
| Since Launch | +48.3% | +19.16% |
Holdings as on 8 May 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 68.70 | 12.35 |
| JB Chemicals & Pharmaceuticals Ltd | 49.55 | 8.90 |
| Lupin | 32.11 | 5.77 |
| Divi's Laboratories | 29.58 | 5.31 |
| Apollo Hospitals Enterprise | 23.58 | 4.24 |
| Laurus Labs | 21.86 | 3.93 |
| Fortis Healthcare | 21.42 | 3.85 |
| Max Healthcare Institute | 21.10 | 3.79 |
| Glenmark Pharmaceuticals | 17.66 | 3.17 |
| Krishna Institute Of Medical Sciencs | 17.57 | 3.16 |
Morning Star Rating
Rating:
Risk
Return
Risk & Volitility
0.00
Sharpe Ratio
0.00%
Std. Deviation
--
Tracking Error
--
Alpha
--
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | +13.15% | +26.39% | +14.22% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth | +11.53% | +24.44% | +12.98% |
| WhiteOak Capital Pharma and Healthcare Fund Regular Growth | +15.8% | -- | -- |
| Kotak Healthcare Fund Regular Growth | +13.5% | -- | -- |
| Quant Healthcare Fund Regular Growth | +11.19% | -- | -- |
Results are calculated on CAGR basis
About Fund
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
The WhiteOak Capital Pharma and Healthcare Fund Regular Growth has an AUM of 556.42 crores & has delivered CAGR of 0.00 in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 2.35%. The minimum investment in WhiteOak Capital Pharma and Healthcare Fund Regular Growth is Rs 500 and the minimum SIP is Rs 100.
As per morningstar the risk & return rating of the fund are Medium & Good respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, JB Chemicals & Pharmaceuticals Ltd, Lupin, Divi's Laboratories.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs, Chemical Manufacturing.
Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth. WhiteOak Capital Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.
FAQs
According to the morning star rating WhiteOak Capital Pharma and Healthcare Fund Regular Growth has a Medium risk & Good return.
WhiteOak Capital Pharma and Healthcare Fund Regular Growth is managed by Piyush Baranwal,Ramesh Mantri,Trupti Agrawal,Dheeresh Pathak,Ashish Agrawal.
The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Regular Growth is 2.35%.
The 5 year annualized return on WhiteOak Capital Pharma and Healthcare Fund Regular Growth is 0.00% & it has generated 15.80% in the last 1 year.
The minimum investment in WhiteOak Capital Pharma and Healthcare Fund Regular Growth is 500 Rs.
WhiteOak Capital Pharma and Healthcare Fund Regular Growth has an AUM of 556.42 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.